Literature DB >> 6519161

Physical exercise and binding of digoxin to skeletal muscle--effect of muscle activation frequency.

T Joreteg, T Jogestrand.   

Abstract

Ten healthy subjects who had ingested 0.5 mg digoxin daily for at least 10 days, performed a 1-hour bicycle exercise test on two occasions, 24 h after the latest dose, with the same work load but at two different pedalling rates, 40 and 80 rpm. During exercise the mean digoxin concentration in the thigh muscle increased by 8% at 40 rpm (n.s.) and by 29% at 80 rpm (p less than 0.01). The serum digoxin concentration decreased by 39% at both pedalling rates (p less than 0.001). The results suggest that the increase in skeletal muscle digoxin concentration during exercise is related to the neuromuscular activation frequency. The digoxin concentration in erythrocytes was measured in 16 healthy subjects before and 1 minute after a 1-hour bicycle exercise test. The erythrocyte digoxin concentration decreased by 12% (p less than 0.01) during the exercise indicating that the increased uptake of digoxin in skeletal muscle during exercise influences the digoxin concentration in other tissues.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6519161     DOI: 10.1007/bf00556893

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  The relation between force, velocity and integrated electrical activity in human muscles.

Authors:  B BIGLAND; O C LIPPOLD
Journal:  J Physiol       Date:  1954-01       Impact factor: 5.182

2.  Influence of myocardial mechanical activity and coronary blood flow on myocardial digoxin uptake.

Authors:  B L Lloyd; R R Taylor
Journal:  Cardiovasc Res       Date:  1976-07       Impact factor: 10.787

3.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors:  T W Smith; V P Butler; E Haber
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

4.  Physical exercise and digoxin binding to skeletal muscle: relation to exercise intensity.

Authors:  T Joreteg; T Jogestrand
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  The effect of heart rate on myocardial ouabain uptake and on the susceptibility to ouabain cardiotoxicity in the dog.

Authors:  B L Lloyd; R R Taylor
Journal:  Clin Exp Pharmacol Physiol       Date:  1978 Mar-Apr       Impact factor: 2.557

6.  Digoxin concentration in right atrial myocardium, skeletal muscle and serum in man: influence of atrial rhythm.

Authors:  T Jogestrand
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

7.  Skeletal muscle digoxin concentration and its relation to serum digoxin concentration and cardiac effect in healthy man.

Authors:  T Jogestrand; K Sundqvist
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

8.  The influence of heart rate on digoxin-induced inhibition of myocardial Na+-K+-ATPase activity in the dog.

Authors:  A J Marsh; B L Lloyd; R R Taylor
Journal:  Clin Exp Pharmacol Physiol       Date:  1981 May-Jun       Impact factor: 2.557

  8 in total
  8 in total

1.  Influence of physical exercise on serum digoxin concentration and heart rate in patients with atrial fibrillation.

Authors:  H E Bøtker; P Toft; N A Klitgaard; E E Simonsen
Journal:  Br Heart J       Date:  1991-06

Review 2.  Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens?

Authors:  R J Dobbs; C J O'Neill; A A Deshmukh; P W Nicholson; S M Dobbs
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

Review 3.  The influence of cardiovascular physiology on dose/pharmacokinetic and pharmacokinetic/pharmacodynamic relationships.

Authors:  Pietro Fagiolino; Rosa Eiraldi; Marta Vázquez
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Transdermal patch drug delivery interactions with exercise.

Authors:  Thomas L Lenz; Nicole Gillespie
Journal:  Sports Med       Date:  2011-03-01       Impact factor: 11.136

Review 5.  Influence of exercise on the pharmacokinetics of drugs.

Authors:  M A van Baak
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

6.  Effect of salbutamol on digoxin concentration in serum and skeletal muscle.

Authors:  M Edner; T Jogestrand
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 7.  Potential interactions between exercise and drug therapy.

Authors:  Thomas L Lenz; Nancy J Lenz; Michele A Faulkner
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

8.  Digitalis enhances exercise-induced hyperkalaemia.

Authors:  A Nørgaard; H E Bøtker; N A Klitgaard; P Toft
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.